60
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Atomoxetine
Available tablet strengths of atomoxetine: 5 mg, 10 mg, 25 mg, 40 mg. Week 1 participant takes 0.5 mg/kg/day, Week 2: 0.8 mg/kg/day, Week 3: 1.2 mg/kg/day. Potential exists for dose increase at Week 4 to 1.8 mg/kg/day based on clinical global impression-improvement rating at Week 4.
Placebo
Placebo tablets dosages: 5 mg, 10 mg, 25 mg, 40 mg.
Christian Sarkine Autism Treatment Center at Riley Hospital for Children, Indianapolis
Lurie Center - MassGeneral Hospital, Lexington
National Institute of Mental Health (NIMH)
NIH
Massachusetts General Hospital
OTHER